Iron transport-mediated drug delivery using mixed-ligand siderophore-β-lactam conjugates
Open Access
- 1 December 1996
- journal article
- Published by Elsevier in Chemistry & Biology
- Vol. 3 (12) , 1011-1019
- https://doi.org/10.1016/s1074-5521(96)90167-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A New Method for the Synthesis ofN.epsilon.-Acetyl-N.epsilon.-hydroxy-L-lysine, the Iron-Binding Constituent of Several Important SiderophoresThe Journal of Organic Chemistry, 1994
- Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active EffluxScience, 1994
- Inactivation of Antibiotics and the Dissemination of Resistance GenesScience, 1994
- The Biological Warfare of the FutureScience, 1994
- Reviving the Antibiotic Miracle?Science, 1994
- Synthesis of novel citrate-based siderophores and siderophore-.beta.-lactam conjugates. Iron transport-mediated drug delivery systemsThe Journal of Organic Chemistry, 1993
- Microbial iron chelators as drug delivery agents: the rational design and synthesis of siderophore-drug conjugatesAccounts of Chemical Research, 1993
- Iron transport mediated drug delivery systems: synthesis and antibacterial activity of spermidine- and lysine-based siderophore - .beta.-lactam conjugatesBioconjugate Chemistry, 1991
- N5-Acetyl-N5-hydroxy-L-ornithine-derived siderophore-carbacephalosporin .beta.-lactam conjugates: iron transport mediated drug deliveryJournal of Medicinal Chemistry, 1990
- Albomycine, IV. Isolierung und Totalsynthese von (N5‐Acetyl‐N5‐hydroxy‐L‐ornithyl)‐(N5‐acetyl‐N5‐hydroxy‐L‐ornithyl)‐N5‐acetyl‐N5‐hydroxy‐L‐ornithinEuropean Journal of Organic Chemistry, 1984